MediWound: Doubling Sales Even Before Likely FDA Approval - Seeking Alpha
MediWound: Doubling Sales Even Before Likely FDA Approval Seeking Alpha MediWound's stock has taken a beating following a share issuance and 2 previous lackluster quarterly earnings. I believe that with the real-life effectiveness showing of the company's key product NexoBrid, the FDA case has a very high chance of approval.
Statement from FDA Commissioner Scott Gottlieb, MD, on steps to promote development of generic versions of opioids ... - FDA.gov
Debunking False Vaccine Claim FactCheck.org The headline on the story says: ?NOW IT'S OFFICIAL: FDA Announced That Vaccines Are Causing Autism!? But the FDA has made no such announcement, and the only evidence that the story gives to support its claim is the label from a vaccine called Tripedia ...